Company · CIK 0001796280 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Oric Pharmaceuticals, Inc. · ORIC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 SForm 4 → | Sep 25, 7:59 pm EDT | Dominic PiscitelliChief Financial Officer | 600 | $13.50 | $8,103 | 69,828 | −0.85% | 10b5-1 |
| Sep 24, 2026 MForm 4 → | Sep 25, 7:59 pm EDT | Dominic PiscitelliChief Financial Officer | 600 | $4.36 | $2,616 | 70,428 | — | 10b5-1 |
| Aug 26, 2026 SForm 4 → | Aug 28, 4:11 pm EDT | Dominic PiscitelliChief Financial Officer | 77,000 | $13.69 | $1,053,814 | 69,828 | −52.4% | 10b5-1 |
| Aug 26, 2026 MForm 4 → | Aug 28, 4:11 pm EDT | Dominic PiscitelliChief Financial Officer | 77,000 | $4.89 | $376,720 | 146,828 | — | 10b5-1 |
| Jul 24, 2026 SForm 4 → | Jul 28, 4:15 pm EDT | Richard A. HeymanDirector | 13,100 | $12.02 | $157,462 | 206,672 | −5.96% | 10b5-1 |
| Jul 24, 2026 MForm 4 → | Jul 28, 4:15 pm EDT | Richard A. HeymanDirector | 3,500 | $1.60 | $5,600 | 45,300 | — | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 8, 4:35 pm EDT | Richard A. HeymanDirector | 300 | $12.00 | $3,600 | 212,772 | −0.14% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 MForm 4 → | Sep 25, 7:59 pm EDT | Dominic PiscitelliChief Financial Officer | 600 | — | — | 91,900 | — | 10b5-1 |
| Aug 26, 2026 MForm 4 → | Aug 28, 4:11 pm EDT | Dominic PiscitelliChief Financial Officer | 77,000 | — | — | 120,000 | — | 10b5-1 |
| Jul 24, 2026 MForm 4 → | Jul 28, 4:15 pm EDT | Richard A. HeymanDirector | 3,500 | — | — | 30,200 | — | 10b5-1 |